- Report
- July 2024
- 155 Pages
Global
From €3694EUR$4,250USD£3,215GBP
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- December 2025
- 150 Pages
Germany
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- November 2025
- 150 Pages
India
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- November 2025
- 150 Pages
Japan
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- December 2024
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- November 2024
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- August 2024
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- January 2025
- 293 Pages
Global
From €3129EUR$3,600USD£2,723GBP
- Report
- January 2025
- 122 Pages
Europe
From €1304EUR$1,500USD£1,135GBP
- Report
- March 2024
- 123 Pages
Africa, Middle East
From €1304EUR$1,500USD£1,135GBP
- Report
- November 2025
- 150 Pages
China
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- February 2023
- 264 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4215EUR$4,850USD£3,668GBP
- Report
- June 2025
- 158 Pages
Canada
From €4341EUR$4,995USD£3,778GBP
- Report
- August 2024
- 62 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- June 2020
- 464 Pages
Global
From €4259EUR$4,900USD£3,706GBP
- Report
- April 2020
- 71 Pages
Global
From €5215EUR$6,000USD£4,538GBP
From €3042EUR$3,500USD£2,647GBP

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more